Monashee Investment Management LLC Xenon Pharmaceuticals Inc. Transaction History

Monashee Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $2.16 Million - $2.99 Million	85,000 New	85,000 $2.59 Million
Q4 2021 Feb 07, 2022	SELL	$15.6 - $35.4 $2.81 Million - $6.37 Million	-180,000 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$14.86 - $19.45 $2.67 Million - $3.5 Million	180,000 New	180,000 $2.75 Million
Q2 2021 Aug 12, 2021	SELL	$16.81 - $20.0 $174,235 - $207,300	-10,365 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.65 - $21.31 $141,482 - $220,878	10,365 New	10,365 $186,000
Q4 2018 Feb 12, 2019	SELL	$5.61 - $12.62 $448,800 - $1.01 Million	-80,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.0 - $14.9 $720,000 - $1.19 Million	80,000 New	80,000 $1.06 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.